Literature DB >> 7524299

The spectrum of immunohistochemical staining of small-cell lung carcinoma in specimens from transbronchial and open-lung biopsies.

D G Guinee1, N F Fishback, M N Koss, S L Abbondanzo, W D Travis.   

Abstract

Immunohistochemistry is increasingly used as an aid in the diagnosis of small-cell lung carcinoma (SCLC). Previous studies have investigated immunohistochemical staining of SCLC with small numbers of antibodies, but few have examined large series with a broad panel of antibodies. For this reason, the authors examined the distribution and intensity of staining of 20 open-lung biopsy (OLB) and 21 transbronchial biopsy (TBB) specimens of SCLC with a panel of epithelial, neuroendocrine, and hormonal markers. Small-cell lung carcinoma stained most frequently with epithelial markers, followed by neuroendocrine and hormonal markers. Similar percentages of OLB and TBB specimens stained for keratin (100% each) and epithelial membrane antigen (100% and 95%, respectively). Unexpectedly, BER-EP4 stained 100% of OLB specimens. Chromogranin A was the most frequent neuroendocrine marker in OLB and TBB specimens (60% and 47%, respectively) followed by neuron-specific enolase (60% and 33%), Leu-7 (40% and 24%), and synaptophysin (5% and 19%). No neuroendocrine immunohistochemical reactivity was found in 24% of TBB specimens and 20% of OLB specimens. Bombesin was the most sensitive hormonal marker (45% of OLB specimens). These results show that keratin, epithelial membrane antigen, and BER-EP4 are reliable epithelial markers for SCLC in both TBB and OLB specimens. In addition, negative staining for neuroendocrine markers, because it can occur in as many as 25% of cases, should not deter the diagnosis of SCLC.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7524299     DOI: 10.1093/ajcp/102.4.406

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  Serological identification of embryonic neural proteins as highly immunogenic tumor antigens in small cell lung cancer.

Authors:  A O Güre; E Stockert; M J Scanlan; R S Keresztes; D Jäger; N K Altorki; L J Old; Y T Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-11       Impact factor: 11.205

Review 2.  Small cell neuroendocrine carcinoma of the breast: a report of three cases and review of the literature.

Authors:  T Adegbola; C E Connolly; G Mortimer
Journal:  J Clin Pathol       Date:  2005-07       Impact factor: 3.411

3.  Pathological diagnosis and treatment outcome of gastric metastases from small cell lung cancer: A case report.

Authors:  Yanmei Peng; Qing Liu; Ye Wang; Aiping Song; Hua Duan; Yuqin Qiu; Qiang Li; Hui-Juan Cui
Journal:  Oncol Lett       Date:  2019-06-18       Impact factor: 2.967

Review 4.  Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data.

Authors:  Charles M Rudin; John T Poirier; Lauren Averett Byers; Caroline Dive; Afshin Dowlati; Julie George; John V Heymach; Jane E Johnson; Jonathan M Lehman; David MacPherson; Pierre P Massion; John D Minna; Trudy G Oliver; Vito Quaranta; Julien Sage; Roman K Thomas; Christopher R Vakoc; Adi F Gazdar
Journal:  Nat Rev Cancer       Date:  2019-05       Impact factor: 60.716

Review 5.  Current standards for clinical management of small cell lung cancer.

Authors:  Anna F Farago; Florence K Keane
Journal:  Transl Lung Cancer Res       Date:  2018-02

6.  Secretagogin, a novel neuroendocrine marker, has a distinct expression pattern from chromogranin A.

Authors:  Maode Lai; Bingjian Lü; Xiaoming Xing; Enping Xu; Guoping Ren; Qiong Huang
Journal:  Virchows Arch       Date:  2006-09-06       Impact factor: 4.064

Review 7.  Cellular and molecular biology of small cell lung cancer: an overview.

Authors:  Niki Karachaliou; Sara Pilotto; Chiara Lazzari; Emilio Bria; Filippo de Marinis; Rafael Rosell
Journal:  Transl Lung Cancer Res       Date:  2016-02

8.  Immunohistochemistry for assessment of pulmonary and pleural neoplasms: a review and update.

Authors:  Dongfeng Tan; Dani S Zander
Journal:  Int J Clin Exp Pathol       Date:  2008-01-01

Review 9.  Management of small-cell lung cancer: incremental changes but hope for the future.

Authors:  Christine L Hann; Charles M Rudin
Journal:  Oncology (Williston Park)       Date:  2008-11-30       Impact factor: 2.990

10.  Small cell lung cancer.

Authors:  Gregory P Kalemkerian; Wallace Akerley; Paul Bogner; Hossein Borghaei; Laura Qm Chow; Robert J Downey; Leena Gandhi; Apar Kishor P Ganti; Ramaswamy Govindan; John C Grecula; James Hayman; Rebecca Suk Heist; Leora Horn; Thierry Jahan; Marianna Koczywas; Billy W Loo; Robert E Merritt; Cesar A Moran; Harvey B Niell; Janis O'Malley; Jyoti D Patel; Neal Ready; Charles M Rudin; Charles C Williams; Kristina Gregory; Miranda Hughes
Journal:  J Natl Compr Canc Netw       Date:  2013-01-01       Impact factor: 11.908

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.